TipRanks
Go Ultimate55% OFF

EVE Health Group Limited (EVE) Price & Analysis

EVE Stock Chart & Stats

A$0.01-A$0.00(-7.14%)
At close: 4:00 PM EDT
AUD 0.0125AUD 0.015AUD 0.01754 Aug18 Aug31 Aug14 Sep28 Sep12 Oct26 Oct
Day’s Range
AUD 0.01 - AUD 0.01
52-Week Range
AUD 0.01 - AUD 0.03
Previous Close
AUD 0.01
Volume
9,814
Average Volume (3M)
558.35K
Market Cap
AUD 4.76M
Enterprise Value
AUD 4.86M
Total Cash (Recent Filing)
AUD 1.24M
Total Debt (Recent Filing)
AUD 0
Price to Earnings (P/E)
―
Beta
0.21
Next Earnings
Mar 01, 2027
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Low Leverage

A debt-light balance sheet reduces refinancing and interest-rate exposure, preserving financial flexibility while the company restructures. Positive equity also provides a buffer against operating volatility and gives management more capacity to allocate resources without heavy creditor constraints.

Losses Narrowing

The reduction in losses indicates some improvement from the company’s earlier financial trough, even though profitability remains unsustainable. If maintained, this progress could lower the funding required to support operations and create a foundation for eventual operating break-even.

Branded Women’s Health Focus

A focused branded product portfolio gives EVE a defined position within consumer health and women’s wellness rather than relying on an undifferentiated offering. Brand development and category focus can support repeat purchasing and clearer market positioning over time.

Bears Say

Persistent Unprofitability

Persistent losses show that sales are not currently sufficient to cover the company’s cost base, while negative gross profit in the latest period signals particularly severe underlying pressure. This weakens earnings quality and makes sustained self-funded growth difficult.

Declining Revenue

Multi-year revenue contraction indicates that EVE is shrinking rather than scaling, reducing operating leverage and making a path to profitability more difficult. Continued sales declines can also limit investment in product development, marketing, and distribution needed to rebuild demand.

Ongoing Cash Burn

Consistently negative operating and free cash flow means the business is consuming cash instead of funding itself internally. Even with minimal debt, continued burn can draw down balance-sheet resources or increase reliance on external funding, constraining strategic flexibility.

EVE Health Group Limited News

EVE FAQ

What was EVE Health Group Limited’s price range in the past 12 months?
EVE Health Group Limited lowest share price was AU$0.01 and its highest was AU$0.03 in the past 12 months.
What is EVE Health Group Limited’s market cap?
EVE Health Group Limited’s market cap is AU$4.76M.
When is EVE Health Group Limited’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were EVE Health Group Limited’s earnings last quarter?
EVE Health Group Limited released its earnings results on Aug 31, 2026. The company reported -AU$0.003 earnings per share for the quarter.
Is EVE Health Group Limited overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does EVE Health Group Limited pay dividends?
EVE Health Group Limited does not currently pay dividends.
What is EVE Health Group Limited’s EPS estimate?
EVE Health Group Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does EVE Health Group Limited have?
EVE Health Group Limited has 352,326,600 shares outstanding.
What happened to EVE Health Group Limited’s price movement after its last earnings report?
EVE Health Group Limited reported an EPS of -AU$0.003 in its last earnings report. Following the earnings report the stock price went down -6.667%.
Which hedge fund is a major shareholder of EVE Health Group Limited?
Currently, no hedge funds are holding shares in AU:EVE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology